Biotin Anti-Human CD41 Antibody[HIP8]

Biotin Anti-Human CD41 Antibody[HIP8]

The Biotin Anti-Human CD41 Antibody[HIP8] is a highly specific monoclonal antibody that recognizes the human CD41 antigen, also known as platelet glycoprotein IIb/IIIa. This antibody is conjugated with biotin, a small molecule that binds to streptavidin, allowing for easy detection and purification of the target protein. The HIP8 clone has been extensively characterized and validated for use in various applications, including flow cytometry, immunohistochemistry, and western blotting.

CD41 is a transmembrane glycoprotein that is expressed on the surface of platelets and megakaryocytes. It plays a crucial role in platelet aggregation and thrombus formation, making it an important target for research in hemostasis and thrombosis. The Biotin Anti-Human CD41 Antibody[HIP8] has been shown to specifically recognize CD41 in human samples, with minimal cross-reactivity to other antigens. This antibody can be used to study the expression and function of CD41 in various cell types and tissues, as well as to develop diagnostic and therapeutic strategies for platelet-related disorders.

In summary, the Biotin Anti-Human CD41 Antibody[HIP8] is a reliable and versatile tool for studying the CD41 antigen in human samples. Its high specificity and sensitivity make it suitable for a wide range of applications, including flow cytometry, immunohistochemistry, and western blotting. Whether you are investigating platelet biology, thrombosis, or other related fields, this antibody can help you achieve your research goals with confidence.